Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Optima HealthLSE:OPT 20 EV-to-EBITDA is 23.77 as of Aug. 20, 2026, which is 165% above its 10-year median of 8.97. GuruFocus rates LSE:OPT with a GF Score™ of 20/100. The stock has 9 warning signs investors should review. Among 513 Healthcare Providers & Services companies, Optima Health ranks worse than 80.31% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Optima Health's enterprise value is £362.2 Mil.
Optima Health's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was £15.2 Mil. Therefore, Optima Health's EV-to-EBITDA for today is 23.77.
The historical rank and industry rank for Optima Health's EV-to-EBITDA or its related term are showing as below:
LSE:OPT'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.94 Med: 8.97 Max: 23.77
Current: 23.77
During the past 5 years, the highest EV-to-EBITDA of Optima Health was 23.77. The lowest was 6.94. And the median was 8.97.
LSE:OPT's EV-to-EBITDA is ranked worse than 80.31% of 513
companies
in the Healthcare Providers & Services industry
Industry Median: 10.76
vs LSE:OPT: 23.77
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Optima Health's PE Ratio (TTM) for today is calculated as:
Optima Health's share price for today is £2.38.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Optima Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was £0.020.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Optima Health's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LSE:OPT vs VEEV, BTSG, HQY: EV-to-EBITDA Comparison
For the Health Information Services subindustry, Optima Health's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Optima Health EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Optima Health's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Optima Health's EV-to-EBITDA falls into.
Optima Health's current Enterprise Value is £362.2 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Optima Health's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was £15.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Optima Health (LSE:OPT) has a EV-to-EBITDA of 23.77 as of Aug. 20, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Optima Health. This is 165% above median its historical median of 8.97. Over the past decade, Optima Health's EV-to-EBITDA has ranged from 6.94 to 23.77. According to the industry distribution chart, Optima Health ranks #412 out of 513 companies in the Healthcare Providers & Services industry, placing it in the top 80.3%.
Is Optima Health's EV-to-EBITDA too high?
Optima Health's current EV-to-EBITDA of 23.77 is 165% above median its 10-year median of 8.97. Over the past 10 years, this metric has ranged from a low of 6.94 to a high of 23.77. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.76. Optima Health's value of 23.77 is 120.9% above this industry median. Based on the distribution chart, Optima Health ranks #412 out of 513 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Optima Health has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Optima Health's EV-to-EBITDA compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Optima Health ranks #412 out of 513 companies for EV-to-EBITDA. This places Optima Health in the lower half of its industry. The industry median EV-to-EBITDA is 10.76. Optima Health's value of 23.77 is 120.9% above this benchmark. Historically, Optima Health's own EV-to-EBITDA has ranged from 6.94 to 23.77 over the past decade. While the company's 10-year median is 8.97 vs. the industry median of 10.76, Optima Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.76, based on 513 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Optima Health's current EV-to-EBITDA of 23.77 is 120.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Optima Health. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Optima Health's current EV-to-EBITDA is 23.77, which is 165% above median its own 10-year median of 8.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Optima Health stock overvalued right now?
Optima Health (LSE:OPT) has a current EV-to-EBITDA of 23.77. The current EV-to-EBITDA is 23.77, which is 165% above median its 10-year median of 8.97 and 120.9% above the Healthcare Providers & Services industry median of 10.76. Optima Health's overall GF Score™ is 20/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Optima Health (LSE:OPT), the current EV-to-EBITDA is 23.77 as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Optima Health PLC is a provider of technology-enabled corporate health and wellbeing solutions in the occupational health sector. The group offers a comprehensive range of flexible and progressive services, from statutory-driven workplace health surveillance medicals to proactive and preventive interventions, as well as workplace health advice and attendance management assessments. These services are ultimately rehabilitation programs and pathways designed to help people return to work.
20GF Score
Get the complete analysis for LSE:OPT
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:OPT has been successfully added to your 
